LINC00641

ncRNA information

ncRNA name

LINC00641

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

Yes

Biomarker application

Prognosis

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Gastric Adenocarcinoma

Cancer site

qRT-PCR,Western blot,Dual-luciferase assay

Treatment information

Treatment type

Chemotherapy

Drug

Oxaliplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Up

Number of patients

93

Male patients

80

Female patients

78(<60)+95(>=60)

Age range and number

Not available

Research information

PMID

Description

down-regulation of LINC00641 inhibited the autophagy process, making gastric cancer cells more sensitive to oxaliplatin

Tissue resource

gastric cancer tissues and corresponding normal tissues

gastric cancer cell lines MKN45

gastric cancer cell lines SGC7901

gastric cancer cell lines MKN28

Experiment

173


Institute

the First Affiliated Hospital of Yan'an University

American Type Culture Collection

Country

China

United States

Continent

Asia

North Amercian